GSK’s new data underscore important responses with momelotinib for myelofibrosis patients
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform
Move to increase affordability and accessibility for heart failure patients across the country
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Subscribe To Our Newsletter & Stay Updated